A significant development has been the isolation of YK-4-279, an inhibitor of the oncogenic EWS–FLI1 Ets fusion in Ewing's sarcoma identified by library screening to inhibit binding to its interaction partner RHA (RNA helicase A) [61]. Here, EWSR1 is linked to Ewing sarcoma.